As shown in Figure 7, SRPK1 inhibition does modulate VEGF-A exon 8 splicing in SHSY5Y cells, making them a viable model to investigate the neuroprotective role of VEGF-A isoforms in AD-related neurotoxicity. Here, VEGFA is linked to Alzheimer disease.